A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke
astrocytepharma.comGroton, CTBiotechFounded 2014
9 sources
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source gives Groton, CT as the dateline, not as the company’s headquarters. It names additional unnamed participants as “others,” which cannot be identified.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source gives Cambridge, MA as a dateline, not as the company's headquarters. It names additional participants only as “others.”
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release says the round was oversubscribed and included additional unnamed investors; no financing total or valuation is stated.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release says the round was joined by University of Texas Horizon Fund and SideCar Angels, plus unnamed others; unnamed investors are not listed.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $9.5M $40M to date | 2026-09-30 | DeepWork Capital | No recent discussion |
9 sources [ VERIFIED ] read against 4 of 9 sources | ||||
Astrocyte Pharmaceuticals develops small-molecule neuroprotection therapies for people suffering traumatic brain injuries, concussions, stroke, and neurodegenerative disorders.
Checked against 14 sources on Sep 30
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6M | 2021-05-03 | Boston Harbor Angels | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source gives Groton, CT as the dateline, not as the company’s headquarters. It names additional unnamed participants as “others,” which cannot be identified. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: astrocytepharma.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| Pre-A Pre-A financing round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.3M | 2018-06-06 | Kaitai Capital | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source gives Cambridge, MA as a dateline, not as the company's headquarters. It names additional participants only as “others.” [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: astrocytepharma.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| Seed [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.4M | 2017-07-17 | Boston Harbor Angels | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The release says the round was oversubscribed and included additional unnamed investors; no financing total or valuation is stated. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: astrocytepharma.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
| Seed seed financing round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.4M | 2017-03-24 | Boston Harbor Angels | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The release says the round was joined by University of Texas Horizon Fund and SideCar Angels, plus unnamed others; unnamed investors are not listed. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: astrocytepharma.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ AGENT ]company research by the Firecrawl agent | ||||
Also named as backers in company research: Dreavent Capital, Alzheimer’s Drug Discovery Foundation, National Institutes of Health (NIH), Department of Defense Congressionally Directed Medical Research Programs